Risk of mortality and cardiovascular events in patients with chronic obstructive pulmonary disease treated with azithromycin, roxithromycin, clarithromycin and amoxicillin - Milan 2023

Global burden and management of chronic obstructive pulmonary disease

Chair(s): Nagendra Chaudhary, Yunus Colak

Session type: Poster session

Risk of mortality and cardiovascular events in patients with chronic obstructive pulmonary disease treated with azithromycin, roxithromycin, clarithromycin and amoxicillin

Imane Alispahic

EVENTS HOME

Abstract

Previous presentation

Next presentation

Session content

Prevalence and presentation of early stage of chronic obstructive pulmonary disease in China: a national cross-sectional study

Jieping Lei

Poster

Abstract

Changes in COPD treatment in Brazil: Findings from the National Health Surveys

Gabriela Marques

Poster

Abstract

COPD-related mortality through different waves of the COVID-19 pandemic

Gabriella Guarnieri

Poster

Abstract

Characteristics of COPD patients on maintenance inhaled therapy in Hungary

Marta Kamocsai

Poster

Abstract

The economic and health burden of COPD in the Middle East: forecasting through 2050

Elroy Boers

Poster

Abstract

The economic and health burden of COPD in Western Europe: forecasting through 2050

Elroy Boers

Poster

Abstract

Impact of stigma and inhaler counseling among geriatric asthma/COPD patients: a pilot study

Saqib Ahmed-chowdhury

Abstract

Mortality and exacerbations in chronic obstructive pulmonary disease associated with Stenotrophomonas maltophilia. A regional cohort study of 22,689 outpatients.

Christian Philip Ronn

Poster

Abstract

Characteristics and treatment patterns of COPD patients according to GOLD classification in the Philippines

Bernice Ong-dela Cruz

Poster

Abstract

Chronic obstructive pulmonary disease management by pulmonologists in private health care structures in Tizi-Ouzou city (Algeria): a cross-sectional survey.

Kahina Lanani

Abstract

Correlation of COPD Assessment Test score and severity of disease in non-smoking COPD patients.

Ajay Kumar Verma

Abstract

Biomarkers of systemic inflammation are not associated with the risk of COPD exacerbations

Jens Ellingsen

Poster

Abstract

COPD exacerbations during and beyond the COVID-19 pandemic in the UK

Victoria Carter

Poster

Abstract

Anemia and proBNP levels as risk factors for airflow limitation in patients with acute coronary syndrome

Santiago Rodriguez-segade Alonso

Poster

Abstract

Pre-COPD in young adults and COPD later in life: A population-based cross-cohort comparison study

Yunus Colak

Poster

Abstract

Real-world study of vaccine effectiveness decline against SARS-Cov-2 Delta variant in COPD patients

Lorinc Polivka

Poster

Abstract

Risk of mortality and cardiovascular events in patients with chronic obstructive pulmonary disease treated with azithromycin, roxithromycin, clarithromycin and amoxicillin

Imane Alispahic

Abstract

Effect of smoking on the development of chronic obstructive pulmonary disease in young individuals: a nationwide cohort study

Chiwook Chung

Poster

Abstract

Risk of chronic lower respiratory disease prior to development of inflammatory bowel disease: A population-based cohort study

Ulla Moller Weinreich

Poster

Abstract

Dietary flavonoids and ventilatory function in adults from the multinational Burden of Obstructive Lung Disease (BOLD) Study

Mulubirhan Assefa Alemayohu

Poster

Abstract

CDN Connection Issue

The ERS International Congress 2023, Milan

#{title}